{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:03:54Z","timestamp":1780567434841,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,4]]},"DOI":"10.7759\/cureus.110222","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:18:39Z","timestamp":1780564719000},"source":"Crossref","is-referenced-by-count":0,"title":["Antenatal Corticosteroid Exposure in Late Preterm Infants: Clinical Considerations in Diabetic Mothers"],"prefix":"10.7759","author":[{"given":"Hannah","family":"Daniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther S","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpashri","family":"Kesavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Bavisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516783","article-title":"Antenatal betamethasone for women at risk for late preterm delivery","volume":"374","author":"Gyamfi-Bannerman C","year":"2016","unstructured":"Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al.. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016, 374:1311-20. 10.1056\/NEJMoa1516783","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.07.023","article-title":"Society for Maternal-Fetal Medicine Consult Series #58: use of antenatal corticosteroids for individuals at risk for late preterm delivery: replaces SMFM Statement #4, implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016","volume":"225","author":"Reddy UM","year":"2021","unstructured":"Reddy UM, Deshmukh U, Dude A, Harper L, Osmundson SS. Society for Maternal-Fetal Medicine Consult Series #58: use of antenatal corticosteroids for individuals at risk for late preterm delivery: replaces SMFM Statement #4, implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery, August 2016. Am J Obstet Gynecol. 2021, 225:B36-42. 10.1016\/j.ajog.2021.07.023","journal-title":"Am J Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.50.4.515","article-title":"A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants","volume":"50","author":"Liggins GC","year":"1972","unstructured":"Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972, 50:515-25. 10.1542\/peds.50.4.515","journal-title":"Pediatrics"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520290065031","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the effect of corticosteroids for fetal maturation on perinatal outcomes","volume":"273","author":"Gilstrap LC","year":"1995","unstructured":"Gilstrap LC, Christensen R, Clewell WH. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA. 1995, 273:413-8. 10.1001\/jama.1995.03520290065031","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002237","article-title":"Committee Opinion No. 713: antenatal corticosteroid therapy for fetal maturation","volume":"130","year":"2017","unstructured":"Committee Opinion No. 713. antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017, 130:e102-9. 10.1097\/AOG.0000000000002237","journal-title":"Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2006.02.002","article-title":"Risk factors for neonatal morbidity and mortality among \"healthy,\" late preterm newborns","volume":"30","author":"Shapiro-Mendoza CK","year":"2006","unstructured":"Shapiro-Mendoza CK, Tomashek KM, Kotelchuck M, Barfield W, Weiss J, Evans S. Risk factors for neonatal morbidity and mortality among \"healthy,\" late preterm newborns. Semin Perinatol. 2006, 30:54-60. 10.1053\/j.semperi.2006.02.002","journal-title":"Semin Perinatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.4303","article-title":"Neurodevelopmental outcomes after late preterm antenatal corticosteroids: the ALPS follow-up study","volume":"331","author":"Gyamfi-Bannerman C","year":"2024","unstructured":"Gyamfi-Bannerman C, Clifton RG, Tita AT, et al.. Neurodevelopmental outcomes after late preterm antenatal corticosteroids: the ALPS follow-up study. JAMA. 2024, 331:1629-37. 10.1001\/jama.2024.4303","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.0483","article-title":"Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: a systematic review and meta-analysis","volume":"176","author":"Ninan K","year":"2022","unstructured":"Ninan K, Liyanage SK, Murphy KE, Asztalos EV, McDonald SD. Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: a systematic review and meta-analysis. JAMA Pediatr. 2022, 176:e220483. 10.1001\/jamapediatrics.2022.0483","journal-title":"JAMA Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2952","article-title":"\"Late-preterm\" infants: a population at risk","volume":"120","author":"Engle WA","year":"2007","unstructured":"Engle WA, Tomashek KM, Wallman C. \"Late-preterm\" infants: a population at risk. Pediatrics. 2007, 120:1390-401. 10.1542\/peds.2007-2952","journal-title":"Pediatrics"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000297311.33046.73","article-title":"Neonatal mortality and morbidity rates in late preterm births compared with births at term","volume":"111","author":"McIntire DD","year":"2008","unstructured":"McIntire DD, Leveno KJ. Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet Gynecol. 2008, 111:35-41. 10.1097\/01.AOG.0000297311.33046.73","journal-title":"Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.12702","article-title":"US incidence of late-preterm steroid use and associated neonatal respiratory morbidity after publication of the Antenatal Late Preterm Steroids trial, 2015-2017","volume":"5","author":"Clapp MA","year":"2022","unstructured":"Clapp MA, Melamed A, Freret TS, James KE, Gyamfi-Bannerman C, Kaimal AJ. US incidence of late-preterm steroid use and associated neonatal respiratory morbidity after publication of the Antenatal Late Preterm Steroids trial, 2015-2017. JAMA Netw Open. 2022, 5:e2212702. 10.1001\/jamanetworkopen.2022.12702","journal-title":"JAMA Netw Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38547.416493.06","article-title":"Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial","volume":"331","author":"Stutchfield P","year":"2005","unstructured":"Stutchfield P, Whitaker R, Russell I. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ. 2005, 331:662. 10.1136\/bmj.38547.416493.06","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.15413","article-title":"Antenatal steroids and neonatal outcomes in late preterm births with pregestational diabetes","volume":"166","author":"Khanuja K","year":"2024","unstructured":"Khanuja K, Jayakumaran J, Al-Kouatly HB, McLaren RA Jr. Antenatal steroids and neonatal outcomes in late preterm births with pregestational diabetes. Int J Gynaecol Obstet. 2024, 166:767-74. 10.1002\/ijgo.15413","journal-title":"Int J Gynaecol Obstet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-3851","article-title":"Postnatal glucose homeostasis in late-preterm and term infants","volume":"127","author":"Adamkin DH","year":"2011","unstructured":"Adamkin DH. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011, 127:575-9. 10.1542\/peds.2010-3851","journal-title":"Pediatrics"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/children8040281","article-title":"Molecular mechanisms of maternal diabetes effects on fetal and neonatal surfactant","volume":"8","author":"Yildiz Atar H","year":"2021","unstructured":"Yildiz Atar H, Baatz JE, Ryan RM. Molecular mechanisms of maternal diabetes effects on fetal and neonatal surfactant. Children (Basel). 2021, 8:281. 10.3390\/children8040281","journal-title":"Children (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.14028","article-title":"Comparison of neonatal outcomes with and without the administration of betamethasone in late preterm births","volume":"156","author":"Bulut AN","year":"2022","unstructured":"Bulut AN, Cundubey CR, Ceyhan V, Aydin E. Comparison of neonatal outcomes with and without the administration of betamethasone in late preterm births. Int J Gynaecol Obstet. 2022, 156:349-54. 10.1002\/ijgo.14028","journal-title":"Int J Gynaecol Obstet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2022.08.029","article-title":"Late-preterm steroid use among individuals with pregestational diabetes mellitus and with twin gestations","volume":"227","author":"Freret TS","year":"2022","unstructured":"Freret TS, James KE, Melamed A, Gyamfi-Bannerman C, Kaimal AJ, Clapp MA. Late-preterm steroid use among individuals with pregestational diabetes mellitus and with twin gestations. Am J Obstet Gynecol. 2022, 227:788-90.e3. 10.1016\/j.ajog.2022.08.029","journal-title":"Am J Obstet Gynecol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2021-322152","article-title":"Antenatal corticosteroids and neurodevelopmental outcomes in late preterm births","volume":"107","author":"Aviram A","year":"2022","unstructured":"Aviram A, Murphy K, McDonald S, et al.. Antenatal corticosteroids and neurodevelopmental outcomes in late preterm births. Arch Dis Child Fetal Neonatal Ed. 2022, 107:250-5. 10.1136\/archdischild-2021-322152","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1729561","article-title":"Evaluation of hypoglycemia in neonates of women at risk for late preterm delivery: an antenatal late preterm steroids trial cohort study","volume":"40","author":"Gyamfi-Bannerman C","year":"2023","unstructured":"Gyamfi-Bannerman C, Jablonski KA, Blackwell SC, et al.. Evaluation of hypoglycemia in neonates of women at risk for late preterm delivery: an antenatal late preterm steroids trial cohort study. Am J Perinatol. 2023, 40:532-8. 10.1055\/s-0041-1729561","journal-title":"Am J Perinatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1055\/a-2624-8405","article-title":"Late preterm antenatal corticosteroids in pregestational and gestational diabetic pregnancies","volume":"42","author":"Haizler-Cohen L","year":"2025","unstructured":"Haizler-Cohen L, Alzamora MC, Legro NR, et al.. Late preterm antenatal corticosteroids in pregestational and gestational diabetic pregnancies. Am J Perinatol. 2025, 42:1798-808. 10.1055\/a-2624-8405","journal-title":"Am J Perinatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-021-01267-4","article-title":"Neonatal hypoglycemia after antenatal late preterm steroids in individuals with diabetes","volume":"41","author":"Dude AM","year":"2021","unstructured":"Dude AM, Yee LM, Henricks A, Eucalitto P, Badreldin N. Neonatal hypoglycemia after antenatal late preterm steroids in individuals with diabetes. J Perinatol. 2021, 41:2749-53. 10.1038\/s41372-021-01267-4","journal-title":"J Perinatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/493800-antenatal-corticosteroid-exposure-in-late-preterm-infants-clinical-considerations-in-diabetic-mothers","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:18:39Z","timestamp":1780564719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/493800-antenatal-corticosteroid-exposure-in-late-preterm-infants-clinical-considerations-in-diabetic-mothers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.110222","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,4]]}}}